Is the inverse relation between blood pressure and mortality normalized in 'low-risk' dialysis patients?

Journal of Hypertension

Volumn 28, Issue 3, 2010, Pages 439-445

  Bos, Willem J W ^a   Van Manen, Jeannette G ^b   Noordzij, Marlies ^c   Boeschoten, Elisabeth W ^e   Krediet, Raymond T ^d   Dekker, Friedo W ^f  

^a ST ANTONIUS HOSPITAL   (Netherlands)

^b UNIVERSITY OF TWENTE   (Netherlands)

^c Department of Medical Informatics ^*  (Netherlands)

^d ACADEMIC MEDICAL CENTER   (Netherlands)

^e Hans Mak Institute   (Netherlands)

^f LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Hemodialysis; Hypertension; Mortality

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE MEASUREMENT; COMORBIDITY; DEATH; DIASTOLIC BLOOD PRESSURE; FEMALE; FOLLOW UP; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PULSE PRESSURE; SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION;

EID: 77149151881     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e3283349a3c     Document Type: Article

References (20)

1. Gasowski J, Fagard RH, Staessen JA, Grodzicki T, Pocock S, Boutitie F, et al. Pulsatile blood pressure component as predictor of mortality in hypertension: a meta-analysis of clinical trial control groups. J Hypertens 2002; 20:145-151.
2. Agarwal R. Hypertension and survival in chronic hemodialysis patients: past lessons and future opportunities. Kidney Int 2005; 67:1-13.
3. Kalantar-Zadeh M, Block G, Humphreys MH, Kopple JD. Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients. Kidney Int 2003; 67:793-808. (Pubitemid 36315558)
4. Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE. Impact of hypertension on cardiomyopathy, morbidity and mortality in end-stage renal disease. Kidney Int 1996; 49:1379-1385.
5. Stenvinkel P, Heimburger O, Paultre F, Diczfalusy U, Wang T, Berglund L, Jogestrand T. Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int 1999; 55:1899-1911. (Pubitemid 29197978)
6. Davies SJ, Russell L, Bryan J, Phillips L, Russell GI. Co-morbidity, urea kinetics, and appetite in continuous ambulatory peritoneal dialysis patients. Their interrelationship and prediction of survival. Am J Kidney Dis 1995; 26:353-361.
7. Dekker FW, de Mutsert R, van Dijk PC, Zoccali C, Jager KJ. Survival analysis: time dependent effects and time-varying risk factors. Kidney Int 2008; 74:994-997.
8. Zager PG, Nikolic J, Brown RH, Campbell MA, Hunt WC, Peterson D, et al. 'U' curve association of blood pressure and mortality in hemodialysis patients. Kidney Int 1998; 54:561-569.
9. Port FK, Hulbert-Shearon TE, Wolfe RA, Bloembergen WE, Golper TA, Agodoa LY, Young EW. Predialysis blood pressure and mortality risk in a national sample of maintenance hemodialysis patients. Am J Kidney Dis 1999; 33:507-517.
10. Luik AJ, Struijk DG, Gladziwa U, Van Olden RW, Van Hooff JP, De Leeuw PW, Leunissen KM. Diurnal blood-pressure variations in haemodialysis and CAPD patients. Nephrol Dial Transplant 1994; 9:1616-1621.
11. Klassen PS, Lowrie EG, Reddan DN, DeLOng ER, Coladonato JA, Szczech LA, et al. Association between pulse pressure and mortality in patients undergoing maintenance hemodialysis. JAMA 2002; 287:1548-1555.
12. Charra B, Calemard E, Ruffet M, Chazot C, Terrat JC, Vanel T, Laurent G. Survival as an index of adequacy of dialysis. Kidney Int 1992; 41:1286-1291.
13. Foley RN, Herzog CA, Collins AJ. Blood pressure and long-term mortality in United States hemodialysis patients: USRDS Waves 3 and 4 Study. Kidney Int 2002; 62:1784-1790.
14. Kestenbaum B, Gillen DL, Sherrard DJ, Seliger S, Ball A, Stehman-Breen C. Calcium channel blocker use and mortality among patients with end-stage renal disease. Kidney Int 2002; 61:2157-2164. (Pubitemid 34539333)
15. Guerin AP, Blacher J, Pannier B, Marchais SJ, Safar ME, London GM. Impact of aortic stiffness attenuation on survival of patients in end-stage renal failure. Circulation 2001; 103:987-992.
16. Efrati S, Zaidenstein R, Dishy V, Beberashvili I, Sharist M, Averbukh Z, et al. ACE inhibitors and survival of hemodialysis patients. Am J Kidney Dis 2002; 40:1023-1029.
17. Heerspink HJ, Ninomiya T, Zoungas S, De Zeeuw D, Grobbee DE, Jardine MJ, et al. Effect of lowering blood pressure on cardiovascular events and mortality in patients on dialysis: a systematic review and meta-analysis of randomised controlled trials. Lancet 2009; 373:1009-1015.
18. van Manen JC, van Dijk PC, Stel VS, Dekker FW, Cleries M, Conte F, et al. Confounding effect of co-morbidity in survival studies in patients on renal replacement therapy. Nephrol Dial Transplant 2007; 22:187-195.
19. Noordzij M, Korevaar JC, Bos WJW, Boeschoten EW, Dekker FW, Bossuyt PM, Krediet RT. Mineral metabolism and cardiovascular morbidity and mortality risk: peritoneal dialysis patients compared with hemodialysis patients. Nephrol Dial Transpl 2006; 21:2513-2520.
20. Hermans MM, Brandenburg V, Ketteler M, Kooman JP, Van der Sande FM, Boeschoten EW, et al. Association of serum fetuin-A levels with mortality in dialysis patients. Kidney Int 2007; 72:202-207.